Pearl River Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,806
| Closed | -$462K | – | 472 |
|
|
2023
Q4 | $462K | Sell |
5,806
-4,129
| -42% | -$329K | 0.07% | 330 |
|
|
2023
Q3 | $694K | Sell |
9,935
-6,453
| -39% | -$451K | 0.11% | 272 |
|
|
2023
Q2 | $1.18M | Buy |
16,388
+6,766
| +70% | +$486K | 0.19% | 170 |
|
|
2023
Q1 | $593K | Buy |
9,622
+1,960
| +26% | +$121K | 0.09% | 289 |
|
|
2022
Q4 | $591K | Buy |
+7,662
| New | +$591K | 0.1% | 294 |
|
|
2020
Q2 | – | Sell |
-3,473
| Closed | -$204K | – | 302 |
|
|
2020
Q1 | $204K | Buy |
+3,473
| New | +$204K | 0.39% | 79 |
|